Home › US companies › Henry Schein

Henry Schein

HSIC · Nasdaq · Wholesale-Medical, Dental & Hospital Equipment & Supplies
Insider buys (12 months)
$692K
Insider sales (12 months)
$8.6M
8-K reports (12 months)
12
Tracked investors holding
0

At a glance

Henry Schein reported 2025 revenue of $13.18B, up 4% from $12.67B in 2024. Over 4 years since 2021 ($12.4B), that is growth of about 1.5% a year. Operating margin was 5%, down from 6.9% in 2021. 2025 was the highest revenue year in this period.

In the last 12 months 6 insiders reported 1 open-market purchase ($692K) and 6 sales ($8.6M). None of the sales were flagged as 10b5-1 plan trades. The largest was a sale of $4M by Chairman, CEO Stanley M Bergman on Feb 27, 2026. Net, insiders were sellers of $7.9M.

Henry Schein filed 12 current reports (Form 8-K) in the last 12 months, most often for officer or director change (4), results of operations (4), material agreement (3) and new financial obligation (2). The latest officer or director change was reported on Oct 8, 2026. It reported a material agreement or a completed acquisition or disposal 3 times.

Annual results

2021
Revenue $12.4B
Op. $852M
2022
Revenue $12.65B
Op. $747M
2023
Revenue $12.34B
Op. $615M
2024
Revenue $12.67B
Op. $621M
2025
Revenue $13.18B
Op. $653M
RevenueOperating income (or net income)SEC XBRL annual filings, fiscal years mapped to calendar years
Year20212022202320242025
Net income$660M$566M$436M$398M$419M
Diluted EPS$4.45$3.91$3.16$3.05$3.27

Fiscal year ends Dec 26 · incorporated in DE

Current reports (8-K, last 12 months)

Insider open-market trades (last 12 months)

Source: SEC EDGAR. How figures are combined